Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DMK Pharmaceuticals (DMKPQ)
OTHER OTC:DMKPQ
Holding DMKPQ?
Track your performance easily
DMKPQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.57
Previous CloseN/A
Volume2.07K
Average Volume (3M)3.45K
Market Cap
$10.00
Enterprise ValueN/A
Total Cash (Recent Filing)$4.09M
Total Debt (Recent Filing)$3.07M
Price to Earnings (P/E)―
Beta-31.28
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.18
Shares Outstanding10,102,050
10 Day Avg. Volume4,132
30 Day Avg. Volume3,451
Standard Deviation0.83
R-Squared0.00717
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DMKPQ FAQ
What was DMK Pharmaceuticals’s price range in the past 12 months?
DMK Pharmaceuticals lowest stock price was <$0.01 and its highest was $0.57 in the past 12 months.
What is DMK Pharmaceuticals’s market cap?
DMK Pharmaceuticals’s market cap is $10.00.
When is DMK Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were DMK Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is DMK Pharmaceuticals overvalued?
According to Wall Street analysts DMK Pharmaceuticals’s price is currently Overvalued.
Does DMK Pharmaceuticals pay dividends?
DMK Pharmaceuticals does not currently pay dividends.
What is DMK Pharmaceuticals’s EPS estimate?
DMK Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DMK Pharmaceuticals have?
DMK Pharmaceuticals has 10,102,050 shares outstanding.
What happened to DMK Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of DMK Pharmaceuticals?
Currently, no hedge funds are holding shares in DMKPQ
---
Company Description
DMK Pharmaceuticals
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
---
ACADIA Pharmaceuticals
―
Avadel Pharmaceuticals
―
Neurocrine
―
Intra-Cellular Therapies
―
Axsome Therapeutics
―
---